The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
His M&A background and experience with successful private-equity-backed companies will benefit the company’s growth and diversification strategy
India has the highest prevalence of diabetes globally, with an estimated 77 million people living with the condition and an expected 134 million cases by 2045
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
The first phase of the hospital with 225 beds built over 1.75 lakh square feet will be commissioned in the next 12 months
Minister was briefed on the nationwide dengue situation
Subscribe To Our Newsletter & Stay Updated
